The Algernon Value Proposition
-
Advancing new drug treatments for billion dollar global disease markets.
-
Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
-
Conducting multiple phase II clinical trials.
-
Highly capital efficient business model.
-
Experienced management team & globally recognized medical advisory board.